Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Jan 18, 2019 4:56pm
175 Views
Post# 29253812

RE:RE:RE:slide 20#4 Three point MACE event accumulation now stands..

RE:RE:RE:slide 20#4 Three point MACE event accumulation now stands.. Fuzzy,

No disagreement here. To simplify, comes down to 3 scenarios. #1 and #2 are the ones in play right now based on available info. As of now, #3 is just hypothetical but would come into play if 250 not reached in 25 days.

1) 250 events have already been achieved, but no press release issued. 10-15 events per month was correct.

2) 250 events not yet achieved. 10-15 events per month could still be correct if 250 is reached by 2/12/19 (assuming at 200 at AGM 9/12/18 and adding 10 per month). Whether or not a press release comes along is another issue.

3) 250 events not yet achieved. If 250 not reached by 2/12/19, then the 10-15 events per month is incorrect (assuming at 200 at AGM 9/12/18) and rate of events per month for past 5 months is less than 10 per month.

BDAZ
Bullboard Posts